Esperite

Esperite Current Assets

Delisted

The Current Assets of Esperite (ESP.AS) as of Nov 16, 2026 is 8.20 M EUR. In the previous year, Current Assets was 9.54 M EUR — a change of -14.06% (lower).

Current Assets

8.20 MEUR

YoY

-14.06%

Last updated:

Current Assets of Esperite is 2017 8.20 M EUR. Current Assets of Esperite was 2016 9.54 M EUR. It decreases by -14.06% lower compared to the previous year.

The Esperite Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2010
18.41 M EUR
Jan 1, 2011
18.83 M EUR
Jan 1, 2012
21.44 M EUR
Jan 1, 2013
18.68 M EUR
Jan 1, 2014
14.29 M EUR
Jan 1, 2015
13.59 M EUR
Jan 1, 2016
9.54 M EUR
Jan 1, 2017
8.20 M EUR
The Esperite Current Assets history
YEARCurrent AssetsYoY
8.20 MEUR-14.06%
9.54 MEUR-29.77%
13.59 MEUR-4.91%
14.29 MEUR-23.53%
18.68 MEUR-12.87%
21.44 MEUR+13.88%
18.83 MEUR+2.28%
18.41 MEUR+6.23%
17.33 MEUR+20.77%
14.35 MEUR-70.20%
48.15 MEUR+410.06%
9.44 MEUR+63.04%
5.79 MEUR+126.17%
2.56 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Esperite Stock analysis

What does Esperite do? Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Esperite stock

Current Assets of Esperite is 8.20 M EUR in 2017.

Current Assets of Esperite changed from 9.54 M EUR to 8.20 M EUR, representing a -14.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Esperite since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Esperite historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Esperite

All Key Metrics — Esperite